The purpose of this study was to elucidate the effects of dietary supplemented cycloinulooligosaccharides (CF) on the intestinal immune function and humoral immunity in BALB/c mice. The mice were orally administered with a control diet or a diet containing 5% CF for 6 weeks. The fecal IgA level, an indicator of the intestinal immune response, was increased dramatically by 5% CF feeding, and casein-specific IgA in the feces was also significantly increased. The amounts of short-chain fatty acids (SCFA) in the cecal contents and feces were significantly higher in the 5% CF group than in the control group. On the other hand, CF administration had only a slight affect on the plasma IgA and IgG levels and no effect on the plasma IgE and IgM levels. These results indicate that dietary CF upregulated the intestinal immune response, but not the humoral immune response. Furthermore, the dosedependent effect of CF feeding on IgA and SCFA production was examined. Significant increases in the fecal IgA and SCFA levels were observed in the mice fed with 5% CF, but not in the 1% and 2.5% CF-fed groups, indicating that the amount of CF administered was an important factor for up-regulation of the intestinal immune function.
The purpose of this study was to elucidate the effects of dietary supplemented cycloinulooligosaccharides (CF) on the intestinal immune function and humoral immunity in BALB/c mice. The mice were orally administered with a control diet or a diet containing 5% CF for 6 weeks. The fecal IgA level, an indicator of the intestinal immune response, was increased dramatically by 5% CF feeding, and casein-specific IgA in the feces was also significantly increased. The amounts of short-chain fatty acids (SCFA) in the cecal contents and feces were significantly higher in the 5% CF group than in the control group. On the other hand, CF administration had only a slight affect on the plasma IgA and IgG levels and no effect on the plasma IgE and IgM levels. These results indicate that dietary CF upregulated the intestinal immune response, but not the humoral immune response. Furthermore, the dosedependent effect of CF feeding on IgA and SCFA production was examined. Significant increases in the fecal IgA and SCFA levels were observed in the mice fed with 5% CF, but not in the 1% and 2.5% CF-fed groups, indicating that the amount of CF administered was an important factor for up-regulation of the intestinal immune function.
Key words: cycloinulooligosaccharide; IgA; gastrointestinal immune function; prebiotics; shortchain fatty acids (SCFA)
Cycloinulooligosaccharides (CF) discovered in 1989 by Kawamura et al. 1) are cyclic oligosaccharides which consist of six to eight molecules of -(2-1)-linked D-fructofranose units. Cycloinulooligosaccharide fructanotransferase converts inulin, a linear -(2-1)-linked polyfructofuranose chain having a terminal glucose residue, into CF by an intramolecular transfructosylation reaction. CF can be expected to have a variety of functions, because the cyclic feature of CF resembles that of cyclodextrins which have been extensively used in food, medical, and chemical fields. Accordingly, it has already been reported that CF showed the characteristic crown ether-like skeleton, 2) complexation properties with some metal ions, 3) and cryoprotective effects on the freeze-drying of liposome. 4) Fructooligosaccharide, oligofructose, and inulin have been reported to show a variety of physiological activities 5) such as improvement of colonic functions, increased bioavailability of calcium, a triglyceridelowering effect and inhibitory effect on colon carcinogenesis, and they are known to function as prebiotics and dietary fibers. They have recently been found to modulate immune functions. [6] [7] [8] [9] However, there is no report on the physiological function of CF, despite it having almost the same sugar units and linkage type as those of fructooligosaccharide, oligofructose and inulin.
We have recently purified cycloinulooligosaccharide fructanotransferase, which is a CF producing enzyme, from Paenibacillus polymyxa MG-CF6. 10) This work led us to investigate the physiological function of CF. In this present study, we examined the effects of CF on the immune function of mice.
Materials and Methods
Materials. Inulin from chicory roots and bovine serum albumin (fraction V, A-4503) were purchased from Sigma Co. (St. Louis, MO, USA). Casein for an enzyme-linked immunosorbent assay (ELISA) was obtained from Calbiochem. ELISA Quantitation kits for mouse IgA, IgE, IgG, IgG1, IgG2a and IgM, and a TMB peroxidase substrate were purchased from Bethyl Laboratories (Montgomery, TX, USA). ortho-Phenylenediamine dihydrochloride for the peroxidase substrate (OPD-tablet) was purchased from Wako Pure Chemicals (Osaka, Japan). The TMB microwell peroxidase substrate system was obtained from KPL (Gaithersburg, MD, USA). All other chemicals were available products of analytical, GC, or HPLC grade.
Preparation of cycloinulooligosaccharides. Paenibacillus polymyxa MG-CF6 10) was grown in a 7-liters fermenter containing 4 liters of a culture medium composed of inulin (40 g/l), yeast extract (2 g/l),
(0.5 g/l), FeCl 3 (10 mg/l), and CaCO 3 (1 g/l), in tap water (pH 7.0) for 72 h at 35 C. The aeration rate was 3 l/min and agitation speed was 300 rpm. The culture broth (about 3700 ml) was centrifuged at 18;500 Â g for 10 min at 4 C. Solid ammonium sulfate was added to the supernatant to obtain 80% saturation. After standing overnight in a refrigerator, the precipitate was collected by centrifugation and dissolved in about 50 ml of 10 mM sodium phosphate buffer (pH 7.0). The enzyme solution was then dialyzed with 2000 ml of the same phosphate buffer for 24 h in the refrigerator. The dialyzed solution was used as the crude enzyme preparation. The crude enzyme solution was added to 1000 ml of a 10% inulin solution, and the mixture was incubated at 40 C for 48 h. Fructozyme L (4000 U, Novozymes Japan), which contained both endo-and exo-inulinase, was added to the reaction mixture, and the solution was incubated for 1 h at 60 C. After heating for 10 min in a boiling water bath, the reaction mixture was applied to a column (100 Â 950 mm, 7460 ml) of charcoal-celite which had been equilibrated with distilled water. The column was washed with 30 liters of distilled water and then eluted y To whom correspondence should be addressed. Fax: +81-54-648-2001; E-mail: fnanjo@mitsui-norin.co.jp Abbreviations: CF, cycloinulooligosaccharides; SCFA, short-chain fatty acids; ELISA, enzyme-linked immunosorbent assay; OPD, orthophenylenediamine; Ig, immunoglobulin with 25 liters of a 30% ethanol solution. The effluent was evaporated and lyophilized to give about 45 g of CF (the ratio of cycloinulohexaose and cycloinuloheptaose was about 5:2).
Analytical methods. The short-chain fatty acids (SCFA) were analyzed by a TRACE GC 2000 system (Agilent Technologies, CA, USA; EI ionization) with a column (0:25 mm Â 30 m) of Spelco NUKOL (Sigma-Aldrich Japan, Tokyo, Japan) for free acid. Helium was used as the carrier gas at a pressure of 100 kPa, with the column temperature programmed to 150 C for 2 min and then increased at 5 C/min up to 175 C. Formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, and valeric acid were used to prepare standard curves, and heptanoic acid as an internal standard. CF were analyzed by a Waters HPLC system (Nihon Waters, Tokyo, Japan) equipped with a Shodex RI-101 detector (Showa Denko, Tokyo, Japan) under the following conditions: column, MCIGEL CK04SS (10 Â 200 mm; Mitsubishi Chemical Co., Tokyo, Japan); mobile phase, distilled water; column temperature, 60 C; flow rate; 0.3 ml/min. Animals. Female 3-week-old BALB/c mice were obtained from Japan SLC (Hamamatsu, Japan) and housed in a room at 23 AE 3 C and 50 AE 5% relative humidity, with a 12 h light-dark cycle. The mice were fed on a pelleted diet (Rodent Lab Diet EQ, Japan SLC) for a week and then fed on the control group experimental diet ( Experimental design and diets. In experiment 1, the mice were divided into two groups (9 mice per group). Each of the groups was fed on the control diet or 5% CF diet for 6 weeks. In experiment 2, the mice were divided into four groups (7 mice per group), and each of the four groups was fed on the control, 1%, 2.5%, or 5% CF diet for 4 weeks. In these experiments, the mice were housed individually in cages and were given the assigned experimental diets and water ad libitum throughout the experimental period. Table 1 indicates the detailed composition of each diet which was prepared by reference to the diets reported by Hosono et al.
6)
Preparation of the blood, intestinal tissue, and spleen samples. In experiment 1, blood samples were collected from the tail vein with heparinized hematocrit tubes after 4 weeks. After 6 weeks, the mice were anesthetized with sodium thiopental and then sacrificed. Blood samples were collected by means of heart puncture with heparinized syringes. The small intestine, cecum, large intestine, and spleen were then carefully removed from the mice and frozen at À80 C until being used.
Measurement of IgA. Fecal samples were collected every week during the experimental periods, frozen at À20 C, and then lyophilized. The resulting fecal powder was stored at À80 C before use. The fecal powder (0.1 g) was added to 1 ml of 10 mM sodium phosphate buffer containing 0.85% NaCl (PBS) at pH 7.4 and was allowed to stand for 2 h in an ice-water bath. The mixture was homogenized by a Physcotron NS-60 (NITI-ON Medical & Physical Instruments MGF, Tokyo, Japan) and centrifuged at 18;000 Â g and 4 C. The supernatant was diluted appropriately with 50 mM Tris-HCl buffer (pH 8.0) containing 0.14 M NaCl, 1% bovine serum albumin (BSA), and 0.05% Tween 20 for ELISA. Samples of the colon (0.1 g) and small intestine (0.4 g) with their contents were added to 1 ml of 50 mM TrisHCl buffer (pH 7.4) containing 5 mM EDTA and a 1% protease inhibitor cocktail for mammalian tissues (Sigma, MO, USA), homogenized by the Physcotron in an ice-water bath, and then centrifuged at 18;000 Â g and 4 C. The resulting supernatant was diluted in the same manner as just described. Total IgA was measured with a mouse IgA ELISA quantitation kit according to the manufacturer's protocol (Bethy), using a Nunc-immuno plate treated with Maxisorp (eBioscience, CA, USA). OPD was used as the substrate for the enzymatic reaction. The optical density of each well was read at 492 nm with an MTP-32 microplate reader (Corona Electric Co., Hitachinaka, Japan). The IgA concentrations were calculated from standard curves according to the kit protocol. To measure the caseinspecific IgA in the feces, the Nunc plates were coated with casein (10 mg/ml) in 50 mM NaHCO 3 solution (pH 9.6) instead of goat antimouse IgA. The other procedures were performed in the same way as indicated by the kit protocol. A TBA microwell peroxidase substrate system (KPL) was used for enzymatic reaction, and the absorbance at 450 nm was measured with the Corona microplate reader. For the measurement of casein-specific IgA, the specific IgA levels are expressed as the absorbance at 450 nm, because no IgA standard was commercially available.
Measurement of plasma immunoglobulins. Blood samples were withdrawn in the 4th and 6th weeks, and plasma samples were prepared by centrifugation. The plasma samples were appropriately diluted with 50 mM Tris-HCl buffer (pH 8.0) containing 0.14 M NaCl, 1% BSA, and 0.05% Tween 20. Each amount of IgA, IgE, IgG, IgG1, IgG2a, and IgM was measured with the corresponding mouse immunoglobulin ELISA quantitation kit and protocol (Bethy), and with OPD as the peroxidase substrate.
Analysis of short-chain fatty acids (SCFA). Wet feces (0.2 g) and the cecal contents (0.2 g) stored at À80 C were added to 0.48 ml of water and 0.08 ml of 0.5 M phosphoric acid, and the mixture was allowed to stand for 24 h in a refrigerator. The mixture was homogenized with vigorous shaking. To the mixture, 0.06 ml of 0.5% heptanoic acid as an internal standard, 0.8 ml of ethanolmethanol (2:8 v/v) and 0.08 ml of chloroform-methanol (2:1 v/v) were added and homogenized well with a vortex mixer (Scientific Industries, NY, USA). The suspension was centrifuged at 3000 rpm for 20 min at 4 C. The supernatant was further passed through a membrane filter, and the resulting solution was analyzed by GC-MS as described in the ''Materials and Methods section.'' Analysis of the CF contents in feces. The fecal samples (0.1 g) were suspended in 1 ml of PBS (pH 7.4), mixed well by the Pyscotron, and then centrifuged. After filtering the supernatant with a membrane filter (0.45 mm), the solution was analyzed by HPLC as described in the ''Materials and Methods section.'' The degree of CF excreted in the feces (%) was calculated as follows: 100 Â CF in feces per day=CF in food intake per day:
Statistical analyses. Each result is expressed as the mean value with its standard deviations (mean AE SD). The statistical difference from the value for the control group in experiment 1 was analyzed by Student's t-test for a parametric analysis and by the Mann-Whitney U-test for a non-parametric analysis. The statistical difference from the control value in experiment 2 was analyzed by Dunnett's test. The statistical calculations were done with SPSS 13.0 computer software (SPSS Japan, Tokyo, Japan). Differences are considered significant at p < 0:05. 
Results
Effects of CF feeding on the intestinal and fecal IgA contents, plasma antibody levels, and SCFA production Food intake, body weight gain, organ weights, and fecal weight
The total food intake and final body weight in the 5% CF group were significantly higher than those in the control group in experiment 1. The weights of the small intestine, cecum and large intestine were not significantly different between the two groups, but the cecal contents were significantly greater in the mice fed with the 5% CF diet. No significant difference in spleen weight was apparent between the two groups. These results are indicated in Table 2 . Both the wet and dry fecal weights in the 5% CF group were significantly higher than those in the control group throughout the course of the experiment as shown in Table 3 .
IgA concentrations in the feces, small intestine, and large intestine
The IgA levels in the fecal extracts were measured every week over the period of experiment 1. The results are illustrated in Fig. 1 . Both the total IgA content and IgA concentration in the 5% CF group rapidly increased in the 1st week and were significantly higher than those in the control group throughout the experimental periods. The concentrations of IgA in the small and large intestines were also determined (Fig. 2) . Although no significant difference in the IgA concentration of the small intestine was observed between the two groups, the IgA concentration in the large intestine of the CF group was significantly higher than that in the control group. The levels of fecal IgA specific to casein, which was a component of the experimental diets, were further examined in the 6th week and are expressed as the absorbance at 450 nm. The specific IgA level in the 5% CF group was significantly higher than that in the control group (mean AE SD (n ¼ 9): 0:413 AE 0:186 vs 0:281 AE 0:230, p < 0:05, Mann-Whitney U-test).
Concentrations of IgA, IgE, IgG, IgG1, IgG2a and IgM in the plasma
The concentrations of IgA and IgG were higher in the mice fed with CF than of those in the control group after The amount of IgA in the total feces (A) and amount per g dry feces (B) were determined as described in the ''Materials and Methods section.'' Control group, filled circles; 5% CF group, unfilled circles. Each value is expressed as the mean AE SD (n ¼ 9). The statistical analysis was carried out with Mann-Whitney U-test.
Significantly different values from the control group:
ÃÃ p < 0:01.
4 weeks of feeding, but no differences were apparent in the 6th week (Table 4 ) in experiment 1. There was little influence of CF feeding on the IgE and IgM levels. In the IgG subclass antibodies, no significant difference in the IgG1 or IgG2a concentration or in their ratio was found either in the 4th or 6th week (Table 4) . Cecal and fecal concentrations of SCFA The amounts of acetic acid, propionic acid and n-butyric acid were determined in the cecal contents and feces in the 6th week (Table 5 ) in experiment 1. CF feeding significantly increased the amounts of acetic acid, n-butyric acid and total SCFA in the cecum as compared with the control group. In the feces, the amounts of propionic acid and total SCFA in the CF group were significantly greater than those in the control group.
Dose-dependent effects of CF feeding on the fecal IgA content and SCFA production
In experiment 2, we examined the dose-dependent effect of CF feeding on the levels of IgA and caseinspecific IgA, and the amounts of SCFA in the feces. In addition, the degree of CF excreted in the feces was estimated.
There were no significant differences in the final body weight, total food intake, and wet and dry fecal weights among the control, 1% CF, 2.5% CF, and 5% CF groups after 4 weeks of feeding (data not shown). The amounts of fecal IgA increased markedly in the 5% CF group, but hardly increased in the 1% and 2.5% CF groups, as compared with those in the control group (Fig. 3) . The level of fecal IgA specific to casein in the 5% CF group was also significantly higher than that in the control group (Table 6) . The amounts of IgA in the small and large intestines of mice fed with 5% CF were compared with those in the control mice. The IgA levels were determined with the small and large intestines containing their contents. Each value is expressed as the mean AE SD (n ¼ 9). The statistical analysis was carried out with Mann-Whitney U-test. Significantly different values from the control group: Ã p < 0:05. The amounts of IgA in the total feces (control, unfilled circles; 1% CF, filled circles; 2.5% CF, unfilled triangles; 5% CF, filled squares) were determined by ELISA as described in the ''Materials and Methods section.'' Each value is expressed as the mean AE SD (n ¼ 7). The statistical analysis was carried out with Dunnet's test. Significantly different values from the control group:
The amounts of fecal SCFA were examined in detail as shown in Table 7 . All of the SCFA measured showed significantly higher values in the 5% CF group in the first week of feeding than those in the control group, whereas no significant differences were found among the control, 1% and 2.5% CF groups. After 4 weeks of feeding, almost the same results were also obtained as those in the first week.
The degree of CF excreted in the feces was calculated as described in the ''Materials and Methods section.'' The degree of fecal CF excreted in the 1%, 2.5%, and 5% CF-fed groups was estimated to be 15.5, 7.1, and 37.5% on average (7 mice per each group), respectively, in the first week, and 18.9, 4.6, and 14.5% at the end of the experiment (4th week).
Discussion
There is little information so far on the physiological function of CF. In experiment 1, we demonstrated that 5% CF feeding to BALB/c mice significantly increased both the IgA content and IgA concentration in the feces (Fig. 1) . The IgA concentration in the large intestine of the 5% CF-fed mice was also significantly higher than that of the control group, but there was no increase in the small intestinal IgA concentration (Fig. 2) . It is presumed that CF acted in the large intestine rather than the small intestine. Nakamura et al. 9) have discussed that the immunomodulating effects of prebiotics such as fructooligosaccharides can be expected to be seen mainly in the colon, because most prebiotics reach the colon intact and are extensively fermented in the colon by intestinal microflora. Indeed, they have indicated that dietary fructooligosaccharides increased the total IgA levels in tissue extracts from the colon. Furthermore, supplementation by 5% CF was found to increase the caseinspecific IgA content in the feces, implying that the intake of CF may mitigate allergic reactions caused by foods. It seems that the increase in casein-specific IgA may be related to the change in the intestinal bacteria by CF feeding, because it has been reported that bifidobacteria enhanced antigen specific IgA levels in milk and feces in lactating mice, which may help to protect pups and dams from exposure to food antigens.
11) Thus, these results suggest that dietary CF had an immunomodulating function in the intestinal immune system.
On the other hand, it was found that 1% and 2.5% CF feeding had no influence on the IgA and casein-specific IgA contents in the feces, despite significant increases of these IgA contents in the mice fed with 5% CF in experiment 2 ( Fig. 3 and Table 6 ). Similarly, the fecal SCFA levels significantly increased in the 5% CF group, but no such increase was apparent in the 1% and 2.5% CF groups as compared with those in the control group (Table 7) . Thus, it appears that SCFA production was connected with the IgA production. In this regard, oligofructose and inulin, which have the same sugar unit and linkage type as those of CF, have been reported to increase the number of bifidobacteria and other SCFAproducing bacteria. 6, 8, 12) The increases in these intestinal bacteria are considered to stimulate IgA production, since the ingestion of bifidobacteria has been reported to induce IgA, including antigen-specific IgA, in the small intestine and feces. 8, 11, 13, 14) Furthermore, it is also assumed that SCFA production increased as a result of the increased numbers of bifidobacteria and SCFAproducing bacteria. In the case of CF, significant increases in the SCFA levels were observed in the cecal contents and feces of the 5% CF-fed mice. Taking into account the above consideration with respect to inulin and oligofructose, these results suggest that 5% CF supplementation induced a shift in the composition of the intestinal microflora toward predominance of bifidobacteria and SCFA-producing bacteria. This shift in the intestinal bacteria may have resulted in the increase in IgA production. On the contrary, no significant increase in either the fecal SCFA or IgA level was apparent in the 1% and 2.5% CF-fed groups. The reason for this is considered to be that relatively small amounts of CF feeding would not have been enough to change the composition of the intestinal microflora. We investigated the effects of dietary CF on plasma immunoglobulins. Dietary CF fed to the mice had no effect on the IgE and IgM levels and had little effect on the IgA and IgG concentrations. The IgG subclass antibodies, IgG1 and IgG2a, in the plasma were also measured, but the levels of IgG1 and IgG2a, and their ratio did not change either in the 4th or 6th weeks. These results suggest that the effect of CF supplementation was not to the extent of influencing a systemic immune response.
We found that the amounts of acetic acid and n-butyric acid in the cecal contents and of propionic acid in the feces increased significantly in the 6th week after 5% CF feeding in experiment 1 ( Table 5 ). The amounts of acetic acid, propionic acid, n-butyric acid, and isobutyric acid in the feces were also found to increase significantly both in the first and 4th weeks after 5% CF feeding in experiment 2 ( Table 7) . On the other hand, a substantial difference in the amount of SCFA detected in the feces was observed between the two experiments (Tables 5 and 7) . This difference was mainly due to the increase in the production of acetic acid and n-butyric acid in experiment 2. The reason for this phenomenon is unclear, but one possible explanation is that the difference in the composition of intestinal bacteria in the mice between the two experiments may have been responsible. However, it was found in experiments 1 and 2 that the amount of SCFA in the feces significantly increased in the 5% CF-fed mice as compared with the control group. It has recently been reported that SCFA may contribute to mucosal barrier functions. Ichikawa et al. 15) have demonstrated that an oral or rectal administration of SCFA (a mixture of acetic acid, propionic acid and butyric acid) stimulated gut epithelial cell proliferation. Morita et al. 16) have reported that mucin production in the gut may be stimulated by SCFA. Butyrate has been found to enhance the cytotoxic activity of natural killer cells and to increase the density of splenic T-helper cells. 7) Thus, there is growing evidence that SCFA affects the mucosal barrier and immune functions. It may be possible that dietary CF also strengthens the mucosal barrier and immune functions through SCFA production in the gut, in addition to enhancing the intestinal IgA production.
We have demonstrated in this study that CF elevated intestinal IgA and SCFA production. It appears that CF acted like prebiotics, since they show an immunomodulating function as well as such prebiotics as fructooligosaccharides, 6, 9) oligofructose and inulin. 8, 17) However, further studies are needed to clarify whether or not CF can be defined as prebiotics.
